Evidence map›Paper›PMID 35881618›Full record

ArticlePloS one2022

Antibiotic treatment duration for bloodstream infections in critically ill children-A survey of pediatric infectious diseases and critical care clinicians for clinical equipoise.

Sandra Pong, Robert A Fowler, Srinivas Murthy, Jeffrey M Pernica, Elaine Gilfoyle, Patricia Fontela, Nicholas Mitsakakis, Asha C Bowen, Winnie Seto, Michelle Science and 4 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Noninferiority Margin Size and Acceptance of Trial Results: Contingent Valuation Survey of Clinician Preferences for Noninferior Mortality.Medical decision making : an international journal of the Society for Medical Decision Making · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 8 institutions in 2 countries.

Sandra PongDepartment of Pharmacy, The Hospital for Sick Children, Toronto, Ontario, Canada.ORCID 0000-0003-2963-9601
Robert A FowlerInterdepartmental Division of Critical Care Medicine, University of Toronto, Toronto Ontario, Canada.
Srinivas MurthyDepartment of Pediatrics, Division of Critical Care, University of British Columbia, Vancouver, British Columbia, Canada.
Jeffrey M PernicaDivision of Infectious Diseases, McMaster University, Hamilton, Ontario, Canada.ORCID 0000-0002-4380-5402
Elaine GilfoyleDepartment of Critical Care Medicine, The Hospital for Sick Children, Toronto, Ontario, Canada.
Patricia FontelaDepartment of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Québec, Canada.
Nicholas MitsakakisChildren's Hospital of Eastern Ontario Research Institute, Ottawa, Ontario, Canada.
Asha C BowenWesfarmers Centre for Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia Perth Children's Hospital, Nedlands, Western Australia, Australia.
Winnie SetoDepartment of Pharmacy, The Hospital for Sick Children, Toronto, Ontario, Canada.
Michelle ScienceDivision of Infectious Diseases, Department of Paediatric Medicine, The Hospital for Children, Toronto, Ontario, Canada.
James S HutchisonDepartment of Critical Care Medicine, The Hospital for Sick Children, Toronto, Ontario, Canada.
Philippe JouvetPediatric Intensive Care Unit, Sainte-Justine Hospital University Center, Montreal, Québec, Canada.ORCID 0000-0001-5684-3398
Asgar RishuCritical Care Research Unit, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
Nick DanemanDivision of Infectious Diseases, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
Hospital for Sick Children · CASunnybrook Health Science Centre · CAUniversity of Toronto · CACentre Hospitalier Universitaire Sainte-Justine · CAMcGill University · CAMcMaster University · CAThe Kids Research Institute Australia · AUUniversity of British Columbia · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo describe antibiotic treatment durations that pediatric infectious diseases (ID) and critical care clinicians usually recommend for bloodstream infections in critically ill children.

designAnonymous, online practice survey using five common pediatric-based case scenarios of bloodstream infections.

settingPediatric intensive care units in Canada, Australia and New Zealand.

participantsPediatric intensivists, nurse practitioners, ID physicians and pharmacists.

main outcome measuresRecommended treatment durations for common infectious syndromes associated with bloodstream infections and willingness to enrol patients into a trial to study treatment duration.

resultsAmong 136 survey respondents, most recommended at least 10 days antibiotics for bloodstream infections associated with: pneumonia (65%), skin/soft tissue (74%), urinary tract (64%) and intra-abdominal infections (drained: 90%; undrained: 99%). For central vascular catheter-associated infections without catheter removal, over 90% clinicians recommended at least 10 days antibiotics, except for infections caused by coagulase negative staphylococci (79%). Recommendations for at least 10 days antibiotics were less common with catheter removal. In multivariable linear regression analyses, lack of source control was significantly associated with longer treatment durations (+5.2 days [95% CI: 4.4-6.1 days] for intra-abdominal infections and +4.1 days [95% CI: 3.8-4.4 days] for central vascular catheter-associated infections). Most clinicians (73-95%, depending on the source of bloodstream infection) would be willing to enrol patients into a trial of shorter versus longer antibiotic treatment duration.

conclusionsThe majority of clinicians currently recommend at least 10 days of antibiotics for most scenarios of bloodstream infections in critically ill children. There is practice heterogeneity in self-reported treatment duration recommendations among clinicians. Treatment durations were similar across different infectious syndromes. Under appropriate clinical conditions, most clinicians would be willing to enrol patients into a trial of shorter versus longer treatment for common syndromes associated with bloodstream infections.

Indexed as

BacteremiaCatheter-Related InfectionsCommunicable DiseasesIntraabdominal InfectionsSepsisAnti-Bacterial AgentsChildCritical CareCritical IllnessDuration of TherapyHumansSurveys and QuestionnairesSyndromeAnti-Bacterial Agents

Identifiers

PMID35881618
PMCPMC9321425
OpenAlexW4288038795

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.